Jane Street’s Achillion Pharmaceuticals ACHN Stock Holding History

Jane Street’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-81,300	Closed	-$720K	–	4385
2015 Q2	$720K	Buy	+81,300	New	+$769K	﹤0.01%	1915
2015 Q1	–	Sell	-14,600	Closed	-$179K	–	3629
2014 Q4	$179K	Buy	+14,600	New	+$178K	﹤0.01%	2262

Jane Street's ACHN Position: Q1 2020 in Review

Jane Street sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 447,447 shares — an estimated $2.7M sold.

Jane Street first reported a position in ACHN in Q3 2013 and held it in 12 quarters. The position peaked at $2.7M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Jane Street reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Jane Street sold 447,447 Achillion Pharmaceuticals shares in Q1 2020, an estimated $2.7M.
Jane Street first reported a position in Achillion Pharmaceuticals in Q3 2013 and held it in 12 quarters.
Jane Street's Achillion Pharmaceuticals position peaked at $2.7M in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Jane Street's 13F filing for Q1 2020, filed 15 May 2020.